CSL Limited (CSLLY) Q2 2026 Earnings Call Transcript
Source: SeekingAlpha
2026-02-10 22:24:20 ET
CSL Limited (CSLLY) Q2 2026 Earnings Call February 10, 2026 6:00 PM EST
Company Participants
Mark Dehring
Gordon Naylor
Ken Lim - Chief Financial Officer
Andy Schmeltz - Chief Commercial Officer
Dave Ross - Senior VP & GM of Seqirus
...
Read the full article on Seeking Alpha
For further details see:
CSL Limited (CSLLY) Q2 2026 Earnings Call Transcript
CSL Ltd. ADR
NASDAQ: CSLLY
CSLLY Trading
0.63% G/L:
$51.985 Last:
68,998 Volume:
$51.97 Open:
CSLLY Latest News
January 27, 2026 02:06:00 pm
Deutsche Bank Appointed as Successor Depositary Bank for the American Depositary Receipt Program of CSL Limited
December 07, 2025 12:01:00 pm
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
CSLLY Stock Data
$59,010,931,430
958,728,992
N/A
5
N/A
Biotechnology & Life Sciences
Healthcare
AU
Prakville Victoria Austra
